| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1011996809 |
| P356 | DOI | 10.1186/1471-230X-12-13 |
| P932 | PMC publication ID | 3292445 |
| P698 | PubMed publication ID | 22316329 |
| P50 | author | Halvor Næss | Q72892640 |
| Trygve Hausken | Q64051500 | ||
| P2093 | author name string | Harald I Nyland | |
| Morten Nyland | |||
| Inghild Follestad | |||
| P2860 | cites work | The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus | Q69772148 |
| Prevalence and incidence of chronic fatigue syndrome in Wichita, Kansas | Q39654932 | ||
| Postinfectious and chronic fatigue syndromes: clinical experience from a tertiary-referral centre in Norway. | Q40362210 | ||
| Life events, difficulties and dilemmas in the onset of chronic fatigue syndrome: a case–control study | Q44689319 | ||
| Chronic Fatigue Syndrome in the Community Prevalence and Associations | Q45138539 | ||
| Fatigue in the general population: a translation and test of the psychometric properties of the Norwegian version of the fatigue severity scale | Q45250666 | ||
| Chronic fatigue in a population-based study of Gulf War veterans | Q45333910 | ||
| Clinical, epidemiologic, and virologic studies in four clusters of the chronic fatigue syndrome | Q46221225 | ||
| Secretory antibodies against Giardia intestinalis in lactating Nicaraguan women. | Q46574536 | ||
| Cognitive-behavioural therapy v. mirtazapine for chronic fatigue and neurasthenia: randomised placebo-controlled trial | Q46725680 | ||
| Sudden vs gradual onset of chronic fatigue syndrome differentiates individuals on cognitive and psychiatric measures. | Q52044866 | ||
| Functional status of persons with chronic fatigue syndrome in the Wichita, Kansas, population | Q21245622 | ||
| A large community outbreak of waterborne giardiasis-delayed detection in a non-endemic urban area | Q21257238 | ||
| Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: prospective cohort study | Q24676579 | ||
| A population-based study of the clinical course of chronic fatigue syndrome | Q24791084 | ||
| The hospital anxiety and depression scale | Q27860968 | ||
| The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group | Q28241826 | ||
| A revised version of the psychoticism scale | Q30051509 | ||
| Short form 36 (SF-36) health survey: normative data from the general Norwegian population | Q31944265 | ||
| Fatigue in the general Norwegian population: normative data and associations | Q32031645 | ||
| Normative data for the HADS from a large non-clinical sample. | Q32052130 | ||
| Measuring health-related quality of life in adolescents and young adults: Swedish normative data for the SF-36 and the HADS, and the influence of age, gender, and method of administration | Q33265236 | ||
| Severity of Giardia infection associated with post-infectious fatigue and abdominal symptoms two years after | Q33518032 | ||
| Sickness absence as a measure of health status and functioning: from the UK Whitehall II study | Q33702918 | ||
| Health-related quality of life in patients with chronic fatigue syndrome: an international study. | Q34087674 | ||
| Chronic fatigue syndrome: a review | Q34174314 | ||
| Patient factors associated with duration of certified sickness absence and transition to long-term incapacity. | Q34224820 | ||
| Disability and chronic fatigue syndrome: a focus on function | Q34322582 | ||
| Precipitating factors for the chronic fatigue syndrome | Q34430540 | ||
| A naturalistic study of the chronic fatigue syndrome among women in primary care | Q34477007 | ||
| Incidence, risk and prognosis of acute and chronic fatigue syndromes and psychiatric disorders after glandular fever | Q34490220 | ||
| Chronic fatigue syndrome: an update focusing on phenomenology and pathophysiology | Q34513394 | ||
| To "lump" or to "split" the functional somatic syndromes: can infectious and emotional risk factors differentiate between the onset of chronic fatigue syndrome and irritable bowel syndrome? | Q34532472 | ||
| Antibiotic or bacterial therapy in post-giardiasis irritable bowel syndrome | Q35007544 | ||
| Follow up of patients presenting with fatigue to an infectious diseases clinic | Q35823607 | ||
| Post-infectious disease syndrome | Q36722447 | ||
| Chronic fatigue syndrome: Is it one discrete syndrome or many? Implications for the "one vs. many" functional somatic syndromes debate. | Q37733869 | ||
| High rate of fatigue and abdominal symptoms 2 years after an outbreak of giardiasis | Q39287360 | ||
| P275 | copyright license | Creative Commons Attribution 2.0 Generic | Q19125117 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P921 | main subject | disability | Q12131 |
| chronic fatigue syndrome | Q209733 | ||
| P304 | page(s) | 13 | |
| P577 | publication date | 2012-02-08 | |
| P1433 | published in | BMC Gastroenterology | Q15759922 |
| P1476 | title | Chronic fatigue syndrome after Giardia enteritis: clinical characteristics, disability and long-term sickness absence | |
| P478 | volume | 12 |
| Q26747503 | A Role for the Intestinal Microbiota and Virome in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)? |
| Q28087795 | Advances in understanding Giardia: determinants and mechanisms of chronic sequelae |
| Q34582559 | Chronic fatigue syndrome 5 years after giardiasis: differential diagnoses, characteristics and natural course |
| Q30380365 | Chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) is associated with pandemic influenza infection, but not with an adjuvanted pandemic influenza vaccine. |
| Q40413500 | Cryptosporidium and Giardia in Danish organic pig farms: Seasonal and age-related variation in prevalence, infection intensity and species/genotypes |
| Q49896144 | Empiric treatment for persistent abdominal symptoms after travel: a practical option for a protracted problem? |
| Q49479077 | Eukaryotes in the gut microbiota in myalgic encephalomyelitis/chronic fatigue syndrome |
| Q27002473 | Extra-intestinal and long term consequences of Giardia duodenalis infections |
| Q47154354 | Factors impacting the illness trajectory of post-infectious fatigue syndrome: a qualitative study of adults' experiences. |
| Q35855220 | Fatigue in adults with post-infectious fatigue syndrome: a qualitative content analysis |
| Q30843149 | From good health to illness with post-infectious fatigue syndrome: a qualitative study of adults' experiences of the illness trajectory. |
| Q40061346 | Giardia lamblia infection increases risk of chronic gastrointestinal disorders. |
| Q34663197 | Immunostimulation in the treatment for chronic fatigue syndrome/myalgic encephalomyelitis |
| Q39269431 | Interactions of Giardia sp. with the intestinal barrier: Epithelium, mucus, and microbiota |
| Q39145300 | Mental Health Disorders Associated with Foodborne Pathogens |
| Q30447974 | Overlap between functional GI disorders and other functional syndromes: what are the underlying mechanisms? |
| Q91608738 | Quality of life and its association with irritable bowel syndrome and fatigue ten years after giardiasis |
| Q48504199 | The Risk of Chronic Gastrointestinal Disorders Following Acute Infection with Intestinal Parasites |
| Q90227537 | Work Rehabilitation and Medical Retirement for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients. A Review and Appraisal of Diagnostic Strategies |
Search more.